State Treasurer State of Michigan reduced its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 16.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,900 shares of the medical instruments supplier’s stock after selling 1,000 shares during the quarter. State Treasurer State of Michigan’s holdings in ICU Medical were worth $1,234,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rhumbline Advisers increased its position in ICU Medical by 1.3% in the 1st quarter. Rhumbline Advisers now owns 45,901 shares of the medical instruments supplier’s stock valued at $10,985,000 after acquiring an additional 575 shares during the period. Texas Permanent School Fund increased its position in ICU Medical by 3.8% in the 1st quarter. Texas Permanent School Fund now owns 11,274 shares of the medical instruments supplier’s stock valued at $2,698,000 after acquiring an additional 414 shares during the period. Raymond James Trust N.A. increased its position in ICU Medical by 47.4% in the 1st quarter. Raymond James Trust N.A. now owns 1,480 shares of the medical instruments supplier’s stock valued at $354,000 after acquiring an additional 476 shares during the period. ARP Americas LP acquired a new stake in ICU Medical in the 1st quarter valued at approximately $212,000. Finally, WCM Investment Management LLC acquired a new stake in ICU Medical in the 1st quarter valued at approximately $1,512,000. Hedge funds and other institutional investors own 91.31% of the company’s stock.

In other news, Director Robert S. Swinney sold 239 shares of ICU Medical stock in a transaction on Monday, July 15th. The stock was sold at an average price of $248.73, for a total transaction of $59,446.47. Following the transaction, the director now directly owns 19,662 shares in the company, valued at approximately $4,890,529.26. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Kevin J. Mcgrody sold 7,344 shares of ICU Medical stock in a transaction on Monday, June 10th. The shares were sold at an average price of $231.68, for a total value of $1,701,457.92. Following the transaction, the insider now owns 7,574 shares in the company, valued at $1,754,744.32. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,583 shares of company stock worth $8,010,904. 11.40% of the stock is owned by insiders.

ICUI has been the topic of several analyst reports. ValuEngine cut ICU Medical from a “hold” rating to a “sell” rating in a research report on Thursday, August 8th. Raymond James cut ICU Medical from a “strong-buy” rating to an “outperform” rating in a research report on Thursday, August 8th. BidaskClub cut ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research cut ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. Finally, TheStreet cut ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday. Two analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. ICU Medical presently has an average rating of “Hold” and a consensus target price of $290.50.

Shares of ICUI stock opened at $168.12 on Wednesday. ICU Medical, Incorporated has a 1 year low of $160.00 and a 1 year high of $312.45. The firm has a market cap of $3.47 billion, a PE ratio of 21.81 and a beta of 0.81. The firm’s fifty day moving average price is $240.83.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.13. ICU Medical had a return on equity of 12.41% and a net margin of 3.56%. The company had revenue of $312.30 million for the quarter, compared to analysts’ expectations of $315.47 million. During the same period last year, the firm earned $2.69 EPS. The firm’s revenue for the quarter was down 13.4% on a year-over-year basis. Equities research analysts predict that ICU Medical, Incorporated will post 6.92 EPS for the current fiscal year.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: Why does the United States have a lingering trade deficit?

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.